Latest News

Volunteers needed in April – would you like to help?

Volunteers provide us with important feedback on patient information. They help us to see if the information is easy to use and understand. We then use this feedback to improve the information for people who may need to use it.  To find out more about taking part please visit our volunteer page. Luto always needs […]

Read more

Top tips for proof reading documents

Proof reading is an important tool that we use at Luto. Whether we’re working on developing a patient information leaflet or writing a study report, proof reading is key to producing high quality, error free work. If you need to proof your own or somebody else’s work, take a look at our ‘Top tips for […]

Read more

Say hello in Glasgow and join us at the DIA Euro-Meeting 2017

Come and meet the Luto team at DIA Euro-Meeting in Glasgow. It’s a three-day event running from 29th to 31st March, attracting over 2500 attendees and more than 500 healthcare companies. You’ll find us on stand F22, come and say hello. See how we can help you make your health information clear and engage your […]

Read more

Patient Safety Awareness Week: March 12th to 18th 2017

This month sees the return of Patient Safety Awareness Week. Founded by the not-for-profit organisation ‘The National Patient Safety Foundation’, the event provides the opportunity to engage with healthcare professionals and patients to highlight the importance of patient safety and help spread this message. As a leading health communications and testing company, patient safety is […]

Read more

Top tips for writing clear information

Writing and designing clear health information is what Luto is all about. We believe that producing clear, understandable information empowers the user. So when working on a document, we apply readability best practice and techniques that we have developed over many years of experience. There are a few simple things that you can do to […]

Read more

Meet the Luto Team at DIA Euro-Meeting in Glasgow this March

The Luto Team will be attending the DIA Euro-Meeting in Glasgow from the 29th to 31st March. It’s an ‘intense and stimulating’ three-day event, attracting over 2500 attendees and more than 500 companies, including Bayer, Novartis, Pfizer, GSK, Merck Serono and Novo Nordisk, not to mention the FDA Regulatory Services and the EMA amongst other […]

Read more

Top tips for recruiting the public for your research project

Here at Luto, our Project Assistants are often responsible for recruiting members of the general public to take part in our studies. Our studies may be in the form of face-to-face interviews or a survey, to see whether different types of health communications meet individual’s needs. Depending upon the kind of study, there might be […]

Read more

Cochrane Library health communication priorities

‘Doctors, clinicians and health professionals are not speaking in a voice that can be understood, especially by marginalised groups’. The Cochrane Collaboration is a global, independent, not-for-profit organisation based in Australia, dedicated to producing up-to-date, accurate information about health policy and healthcare. Their high quality reviews are used internationally to deliver best practice, not only […]

Read more

TOPRA launches new Product Information special interest group

Luto’s co-founder and academic advisor, Professor Theo Raynor recently became a member of the newly formed TOPRA group on Product Information launched in November 2016 at a meeting at their office in London, pictured right.  The group will: provide opportunities to share regulatory knowledge relating to product information across the drug product life cycle via TOPRA, collectively voice […]

Read more

Risk Evaluation & Mitigation Strategies Summit 26th and 27th January

We will be attending the 9th Risk Evaluation & Mitigation Strategies Summit in Arlington, Virginia on the 26th and 27th of this month, the same week President Trump will be sworn into office, so it should be an exciting time to be in Washington! REMS 2017 will feature over thirty speakers from industry, patient advocacy […]

Read more

A warm welcome to Irfan Khalid

Please join us in welcoming a new arrival to our team, Irfan Khalid, who started with us in November 2016 as a Project Assistant. We thought we would ask some searching questions to find out what makes Irfan tick. Q: You have a degree in Biomedical Science and a Masters in Cancer Pharmacology, can you […]

Read more

Do the numbers stack up? Getting to the heart of the matter with statins

Professor Theo Raynor, co-founder and academic advisor to Luto Research supported a recently published study by Lead Author Rebecca Dickinson titled, Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs.  The study formed part of Rebecca’s PhD and was co-funded […]

Read more

Pharma and tech create innovative solutions

Verily Life Sciences, an offshoot of Google’s parent company Alphabet, is no stranger to health tech. The company is also known for its ambitious projects, which to date include a smart contact lens to monitor blood sugar levels, and a wearable that aims to detect the early onset of certain cancers. And this year we’ve […]

Read more

Reverse Advent Calendar Appeal 2016

For the majority of people, Christmas is a welcome celebration that is embraced with open arms. However, for others the festive season can be a bleak prospect and many will face waking up on Christmas Day feeling hungry and hopeless. Whilst flicking through Facebook one evening, I came across a post for a reverse advent calendar. […]

Read more

1-7 December 2016 is Crohn’s and Colitis Awareness Week!

Crohn’s and Colitis are often described as the ‘invisible illness’.  Every 30 minutes someone in the UK is diagnosed with Crohn’s disease or Ulcerative Colitis (the two main forms of Irritable Bowel Disease (IBD)).  Our mission is to make health information clear and underline the importance of using medicines properly for people with long-term illnesses. […]

Read more

Taking silliness very seriously – Christmas Jumper Day 2016

On Thursday 15th December my colleagues and I at Luto will be putting on our warmest, wackiest and most wonderful festive woollies to raise money for this year’s Save the Children’s Christmas Jumper Day appeal. Silliness is set to sweep the nation as millions of people up and down the country donate £2 to sport […]

Read more

Why we are using the wrong language

Professor Theo Raynor – Communicating benefit and harm information. Lecture starts at 4:10 on the video clip The EU ‘Risk Communication on Medicines Workshop’ held in Madrid on 16th and 17th June brought together pharmacovigilance and communication experts from national medicines agencies, and representatives from the World Health Organisation, European Medicines Agency, academia, patients, consumers, and […]

Read more

Luto testing feeds into EMA consultation

Prof Theo Raynor, co-founder and academic advisor to Luto Research responded to 2 recent European Medicines Agency consultations – related to the safety monitoring of medicines (called ‘pharmacovigilance’). Both consultations related to the ‘Risk Management Plan’ which companies have to prepare for all licensed medicines. Prof Raynor’s comments relate specifically to the lay summary of […]

Read more

Patient Information Leaflet ‘Shortcomings’ Report Published

European Union guidance on patient information leaflets (PILs) should include more principles of good information design, and allow for more flexibility in the template for such leaflets. In addition, there should be more input from patients through making ‘user testing’ more iterative, and more care is needed when translating tested leaflets, so that the lay […]

Read more

Join us at the DIA Annual EuroMeeting 6th to 8th April in Hamburg

Luto will be exhibiting at the DIA Annual EuroMeeting which brings stakeholders together to collaborate on when, where and how innovation leads to advances in health care product development.   Professor Theo Raynor, Co-founder and Academic Advisor to Luto will be joining the list of expert speakers during the meeting where you can hear his […]

Read more

Luto support development of educational toolbox on medicines R & D

The European Patients’ Academy (EUPATI) today announced the launch of its new online Toolbox on Medicines Research & Development. The toolbox is available to European patient groups, patient advocates and anyone who is interested in learning more about the medicines research and development (R&D) process. It allows users to freely discover, adapt, and share materials. […]

Read more

Join us at Compamed 16th – 19th November in Düsseldorf

Join us at Compamed, the international meeting point for the supplier market of the ‘med-tech’ industry in Düsseldorf this November. Come and say hello and take a break over coffee with us, you’ll find us in hall 8a on stand R21.  You can also recharge your phone and pick up one of our trade fair survival kits! Got a busy schedule? Make sure we don’t miss […]

Read more

Health Literacy, reducing inequalities and universal precautions

The UCL Institute of Health Equity, led by Professor Sir Michael Marmot has produced a practice resource ‘Improving health literacy to reduce health inequalities’. Our co-founder and academic advisor Professor Theo Raynor was one of a number of experts invited to input into the report, and he outlines here the key messages for him from […]

Read more

Luto newsletter – How clear is your health information?

Luto now provides an even stronger service offering so we’ve put together our first newsletter as a way to tell people about our latest developments. In this first edition, we include a case study on our project with Macmillan Cancer Support, to review and refine the charity’s cancer information booklets. We also welcome Steven our new […]

Read more

Because locations MATTER: Luto launches US office

Luto have finally put roots down in the US and opened our first office within the MATTER community. MATTER is an innovative space which brings together entrepreneurs and industry leaders from a range of fields – including healthcare, IT, medical devices, diagnostics and biopharma – who are passionate about creating products and services that advance the healthcare […]

Read more

Expert input to FDA on Risk Evaluation and Mitigation Strategies (REMS)

A key aim of any research should be to have practical impact – Theo Raynor’s 35 years of research into promoting good consumer medicines information has impacted on policy and practice in the UK and the wider European Union, through input into the European Parliament and the European Medicines Agency. This has been both from an […]

Read more

‘It’s all there in black and white’ – or is it? Improving medicines labelling

Research on the labelling of over-the-counter medicines has been published in the international journal ‘Health Expectations’ with the support of Luto. This is the work of PhD candidate Vivien Tong from the University of Sydney – with one of the co-authors being Professor Theo Raynor, co-founder and academic advisor to Luto. The paper described preliminary […]

Read more